Freespira
Overview
Freespira is an FDA-cleared digital therapeutic designed to help individuals with panic disorder and panic-related anxiety, including symptoms of PTSD. It offers a medication-free, at-home treatment option that complements existing therapies like medication or talk therapy.
The core of Freespira’s approach is teaching users to regulate their breathing patterns. This is based on research linking breathing differences and hypersensitivity to CO2 with panic and PTSD symptoms. The program involves two 17-minute sessions per day over 28 days.
Patients are provided with a compact breathing sensor and a tablet that offers real-time feedback on their breathing. The program also includes training and weekly check-ins with a dedicated Care Specialist, ensuring guided support throughout the treatment period.
Clinical results indicate that a significant percentage of patients using Freespira become panic attack-free by the end of the 28-day treatment, with sustained relief observed 12 months later. It also shows a significant reduction in PTSD symptoms.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- FDA-cleared digital therapeutic
- Medication-free treatment
- At-home use
- 28-day program
- Breathing sensor and real-time feedback tablet
- Personalized Care Specialist support
- Reduces panic attacks and PTSD symptoms
- Complementary to existing therapies
Use Cases
- Treatment of panic disorder
- Management of panic-related anxiety
- Reduction of PTSD symptoms
- Adjunctive therapy for mental health conditions
- Remote patient care for behavioral health
What Physicians Need to Know
Freespira is an FDA-cleared adjunctive treatment for panic disorder and PTSD, focusing on physiological breathing retraining. It can be used alongside existing pharmacological and/or non-pharmacological interventions. Physicians should consider Freespira for patients over 18 years old who have experienced panic attacks, panic disorder, or PTSD symptoms for over a month, and who do not have contraindications such as being pregnant, younger than 13, or having COPD or emphysema. The program involves a 28-day at-home protocol with twice-daily 17-minute breathing sessions and weekly virtual coaching. Clinical studies have shown significant and lasting reductions in symptoms and associated healthcare costs.
Freespira is designed as an at-home treatment that complements existing care, including medication and talk therapy. The system itself includes a compact breathing sensor and a tablet with the Freespira app for real-time feedback. Data from patient sessions is saved by the app for review by a clinician or coach. Freespira has also demonstrated economic benefits, including reductions in medical, emergency department, and pharmacy costs, which may be relevant for health plan and employer integrations.
Details
| Category | Mental & Behavioral Health AI, Patient Engagement & Education |
| Pricing |
Some insurances and health plans cover freespira at no extra cost for eligible members. other health plans and employers may cover freespira with a cost share. out-of-pocket cost is approximately $2000. hsa/fsa accounts can be used, or an interest-free payment plan is available.
|
| Deployment | At-home, via a compact breathing sensor and a tablet with a pre-loaded app. |
| Mobile App | 1 |
| API Available | No |
| Data Export | Unknown |
| Languages | English |
| Training | Unknown |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated Freespira is an FDA-cleared Class II Medical Device. It is indicated as an adjunctive treatment for symptoms associated with panic disorder (PD) and/or post-traumatic stress disorder (PTSD) for adults 18 years of age or older, to be used under the direction of a healthcare professional. In May 2025, Freespira received FDA clearance for adolescents aged 13-17 experiencing stress and anxiety. |
| Integrations | |
| EHR | Not specified |
| Specialties | Family Medicine, Internal Medicine, Psychiatry |
Social Proof
| Customers | unknown |
| Notable | Veterans Affairs (VA) |
Support & Reliability
| Training Provided | Unknown |
What the Web Says
Freespira is an FDA-cleared, at-home breathing treatment for panic disorder and PTSD that aims to retrain breathing patterns and reduce sensitivity to carbon dioxide. The program involves twice-daily 17-minute sessions over four weeks, utilizing a sensor and tablet for real-time feedback, along with weekly coaching. Many users and physicians report significant reductions or elimination of panic attacks and PTSD symptoms, with benefits often lasting up to a year post-treatment.
Overall: PositiveStrengths
- FDA-cleared and clinically proven for panic disorder and PTSD.
- Drug-free and at-home treatment.
- Significant reduction or elimination of panic attacks and PTSD symptoms reported by many users.
- Benefits can be long-lasting, with some studies showing sustained improvement for up to a year.
- Convenient with equipment mailed to your home and online coaching support.
- Empowering for patients to learn self-management skills for panic response.
Limitations
- Some users find it expensive if not covered by insurance.
- Initial anxiety or discomfort during breathing sessions can occur.
- Potential for technical issues with equipment connectivity.
- One Reddit user found it no more effective than a free breathing app for PTSD.
- Limited independent tech reviews available outside of medical contexts.
- Some users experienced poor customer service and rescheduling difficulties.
Based on reviews from: Reddit, Freespira.com, BioSpace, Highmark Health Blog, Digital Therapeutics Alliance, PubMed, Trustpilot, Christopher Fisher, PhD, TelepsychHealth, Medical Device Innovation Consortium
Last updated: 2026-09-20
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Freespira
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Freespira.
How Freespira Works
Freespira, Inc.
